Design, synthesis and anticancer activity of dihydropyrimidinone–semicarbazone hybrids as potential human DNA ligase 1 inhibitors

MedChemComm ◽  
2016 ◽  
Vol 7 (12) ◽  
pp. 2349-2363 ◽  
Author(s):  
Koneni V. Sashidhara ◽  
L. Ravithej Singh ◽  
Mohammad Shameem ◽  
Sarika Shakya ◽  
Anoop Kumar ◽  
...  

A series of rationally designed new class of hLig1 inhibitors with potentin vitroanti-cancer properties is presented.

2010 ◽  
Vol 7 (9) ◽  
pp. 644-649 ◽  
Author(s):  
Ana Maria V. Zbancioc ◽  
Gheorghita N. Zbancioc ◽  
Catalin Tanase ◽  
Anca Miron ◽  
Cornelia Ursu ◽  
...  

2012 ◽  
Vol 50 ◽  
pp. 344-349 ◽  
Author(s):  
E. Rajanarendar ◽  
M. Nagi Reddy ◽  
S. Rama Krishna ◽  
K. Govardhan Reddy ◽  
Y.N. Reddy ◽  
...  

ChemInform ◽  
2012 ◽  
Vol 43 (35) ◽  
pp. no-no
Author(s):  
E. Rajanarendar ◽  
M. Nagi Reddy ◽  
S. Rama Krishna ◽  
K. Govardhan Reddy ◽  
Y. N. Reddy ◽  
...  

2013 ◽  
Vol 36 (1) ◽  
pp. 41-50 ◽  
Author(s):  
Khaled A. M. Abouzid ◽  
Nadia A. Khalil ◽  
Eman M. Ahmed ◽  
Khaled Omar Mohamed

1991 ◽  
Vol 279 (1) ◽  
pp. 141-146 ◽  
Author(s):  
G Ciarrocchi ◽  
M Lestingi ◽  
M Fontana ◽  
S Spadari ◽  
A Montecucco

A total of 19 anthracycline derivatives were tested for their ability to interfere in vitro with the action of the human replicative DNA ligase. Only those with the sugar devoid of unmodified amino groups or with large configurational modifications were found to be inactive. Maximal inhibition of DNA-joining activity was found to require a 4′-deoxy-3′-amino sugar. Self-adenylation of DNA ligase was largely insensitive to these drugs. An important general finding is that slight modifications of the anthracycline structure have pronounced effects on DNA-ligase-inhibitory activity and might be related to the specificity of anthracycline anti-tumour activity.


ChemBioChem ◽  
2002 ◽  
Vol 3 (11) ◽  
pp. 1137-1141 ◽  
Author(s):  
David A. Carcache ◽  
Simone R. Hörtner ◽  
Andreas Bertogg ◽  
Christoph Binkert ◽  
Daniel Bur ◽  
...  

2003 ◽  
Vol 14 (2) ◽  
pp. 685-697 ◽  
Author(s):  
Marcin R. Przewloka ◽  
Paige E. Pardington ◽  
Steven M. Yannone ◽  
David J. Chen ◽  
Robert B. Cary

Several findings have revealed a likely role for DNA ligase IV, and interacting protein XRCC4, in the final steps of mammalian DNA double-strand break repair. Recent evidence suggests that the human DNA ligase IV protein plays a critical role in the maintenance of genomic stability. To identify protein–protein interactions that may shed further light on the molecular mechanisms of DSB repair and the biological roles of human DNA ligase IV, we have used the yeast two-hybrid system in conjunction with traditional biochemical methods. These efforts have resulted in the identification of a physical association between the DNA ligase IV polypeptide and the human condensin subunit known as hCAP-E. The hCAP-E polypeptide, a member of the Structural Maintenance of Chromosomes (SMC) super-family of proteins, coimmunoprecipitates from cell extracts with DNA ligase IV. Immunofluorescence studies reveal colocalization of DNA ligase IV and hCAP-E in the interphase nucleus, whereas mitotic cells display colocalization of both polypeptides on mitotic chromosomes. Strikingly, the XRCC4 protein is excluded from the area of mitotic chromosomes, suggesting the formation of specialized DNA ligase IV complexes subject to cell cycle regulation. We discuss our findings in light of known and hypothesized roles for ligase IV and the condensin complex.


MedChemComm ◽  
2019 ◽  
Vol 10 (1) ◽  
pp. 116-119 ◽  
Author(s):  
Fabrizio Olivito ◽  
Nicola Amodio ◽  
Maria Luisa Di Gioia ◽  
Monica Nardi ◽  
Manuela Oliverio ◽  
...  

In this work we synthesized and tested a series of unsaturated disulfides. Two compounds showed a promising anticancer activity in vitro on A549 lung cancer cells compared to the natural analogue.


2020 ◽  
Vol 20 (15) ◽  
pp. 1559-1571 ◽  
Author(s):  
Sumit Tahlan ◽  
Balasubramanian Narasimhan ◽  
Siong Meng Lim ◽  
Kalavathy Ramasamy ◽  
Vasudevan Mani ◽  
...  

Background: Various analogues of benzimidazole are found to be biologically and therapeutically potent against several ailments. Benzimidazole when attached with heterocyclic rings has shown wide range of potential activities. So, from the above provided facts, we altered benzimidazole derivatives so that more potent antagonists could be developed. In the search for a new category of antimicrobial and anticancer agents, novel azomethine of 2-mercaptobenzimidazole derived from 3-(2- (1H-benzo[d]imidazol-2-ylthio)acetamido)benzohydrazide were synthesized. Results and Discussion: The synthesized analogues were characterized by FT-IR, 1H/13C-NMR and MS studies as well C, H, N analysis. All synthesized compounds were evaluated for in vitro antibacterial activity against Gram-positive (B. subtilis), Gram-negative (E. coli, P. aeruginosa, K. pneumoniae and S. typhi) strains and in vitro antifungal activity against C. albicans and A. niger strains by serial dilution method, the minimum inhibitory concentration (MIC) described in μM/ml. The in vitro anticancer activity of synthesized compounds was determined against human colorectal carcinoma cell line (HCT- 116) using 5-fluorouracil as standard drug. Conclusion: In general, most of the synthesized derivatives exhibited significant antimicrobial and anticancer activities. Compounds 8, 10, 15, 16, 17, 20 and 22 showed significant antimicrobial activity towards tested bacterial and fungal strains and compound 26 exhibited significant anticancer activity.


Sign in / Sign up

Export Citation Format

Share Document